Vimarsana
Biggest News Aggregation in the World

Page 10 - Vaccine Development Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vaccine Development Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vaccine Development Program Today - Breaking & Trending Today

Africa's COVID-19 Vaccination Pace Slows Despite Receipt of Supplies - Vimarsana News

Africa's COVID-19 Vaccination Pace Slows Despite Receipt of Supplies

NAIROBI, KENYA - African health officials say the pace of COVID-19 vaccinations has slowed on the continent, raising concerns about stopping the pandemi

Africa's COVID-19 Vaccination Pace Slows Despite Receipt of Supplies - Vimarsana News

Africa's COVID-19 Vaccination Pace Slows Despite Receipt of Supplies

Health officials are calling on Africans to get inoculated as soon as vaccine arrives through COVAX initiative, which aims for equitable, global access

healthcare workers – NBC 7 San Diego - Vimarsana News

healthcare workers – NBC 7 San Diego

San Diego News, Local News, Weather, Traffic, Entertainment, Breaking News

U.S. readies global Covid vaccine donations - Vimarsana News

U.S. readies global Covid vaccine donations

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. With Katherine Ellen Foley, Rachel Roubein and Emily Martin. On Tap — The U.S. will send about 75 percent of its next batch of Covid shot donations to COVAX, with the rest going directly to allies and priority regions.

Pfizer reports strong first-quarter 2021 results - Vimarsana News

Pfizer reports strong first-quarter 2021 results

Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. Revenues and expenses associated with the Upjohn Business (4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted (2) results. Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within t...